Engin ONAN, Saime PAYDAS, Mustafa BALAL, Onur TAKTAKOĞLU, Ertan KARA

Pentoksifilin Tedavisinin Diyabetik Nefropati Progresyonuna Etkisi

Özet

Anahtar Kelimeler:

Diabetik nefropati, pentoksifilin, proteinüri

The Effect of Pentoxifylline Treatment on Diabetic Nephropathy Progression

Abstract

Keywords:

Pentoxifylline, Diabetic Nephropathy, proteinuria,

PDF

___

Lai TS, Chiang W, Chen Y. Pentoxifylline: Evidence strong enough for renoprotection? J Formos Med Assoc. 2016;115(8):591-592.
Bhanot S, Leehey DJ. Pentoxifylline for diabetic nephropathy: An Important Opportunity to Re-purpose an Old Drug? Curr Hypertens Rep. 2016;18(1):8.
Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW et al. Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: A prospective randomized double-blind multicenter study. Diabetol Metab Syndr 2015;7:64.
Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Chahin J, Méndez ML, Gallego E et al. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. J Am Soc Nephrol. 2015;26(1):220-229.
Fouli GE, Gnudi L. The Future: Experimental therapies for renal disease in diabetes. Nephron. 2019;143(1):3-7.
De Zeeuw D, Remuzzi G, Parving H, Keane WF, Zhang Z, Shahinfar S et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004;65(6):2309–2320.
Wu PC, Wu CJ, Lin CJ, Pan CF, Chen CY, Huang TM et al. Pentoxifylline decreases dialysis risk in patients with advanced chronic kidney disease. Clin Pharmacol Ther. 2015;98(4):442-449.
Rabizadeh S, Firouzabadi FD, Esteghamati S, Afarideh M, Ghajar A et al. Beneficial effects of pentoxifylline plus losartan dual therapy in type 2 diabetes with nephropathy Am J Med Sci. 2018 May;355(5):442-448.
Navarro-González JF, Sánchez-Niño MD, Donate-Correa H, Martín-Núñez E, Ferri C, Pérez-Delgadoet N et al. Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease. Diabetes Care. 2018;41(8):1817-1820.
Tian ML, Shen Y, Sun ZL, Zha Y. Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: A meta-analysis. Int Urol Nephrol. 2015;47(5):815–822.
Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: A 12-month randomized trial. Am J Kidney Dis. 2008;52(3):464-474.